Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about board meeting

27 Apr 2023 Evaluate

Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Friday, 5th May 2023 to consider and approve: Audited Financial Results (consolidated & standalone) of the Company for the quarter and year ended 31st March 2023 and Audited Financial Statements (consolidated & standalone) for the year ended 31st March 2023.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..